News

How to outsource the optical dispensary without sacrificing profits or control

Why surgeons need to understand how to center advanced surgical implants manually

Three keys to managing a successful practice as a leader

Researchers spurred to develop new therapies, strategies for diabetic cataract, retinopathy

Observations of modern American political science seen from the past

Upgrade may make traditional manual lens delivery a thing of the past

Faster treatment times will help reduce variable hydration during ablation

Congressional staff briefed on OCT during World Glaucoma Week

Device safe and effective for both routine and complex surgeries

Different professional certifications come with different qualifications

Compounding pharmacy issues voluntary nationwide recall due to sterility issues

Efficacy is achieved with a favorable safety profile in 1-year study data

Novel amniotic membrane product supports fetal-like healing

How proper anesthesia, timing, approach reduce pain and even risk of endophthalmitis requiring repeat injections

The use of microplasmin (ocriplasmin; Jetrea, ThromboGenics) was evaluated in the Microplasmin for Children (MIC) trial for use in pediatric patients. The results are forthcoming.

Bausch + Lomb (B+L) and Walgreens will collaborate on SightSense, a new online and in-store patient education program to heighten eye health awareness.

Iridex Corp. has entered into a global distribution and supply agreement with Peregrine Surgical Ltd. to become a worldwide distributor for Peregrine labeled products, and Peregrine Surgical will become part of the Iridex supply chain.

Lorenz E. Zimmerman, MD, the founder of modern ophthalmic pathology, who spent his career studying diseases of the eye, died March 16, 2013 of complications from an infection.

Intravitreal injection of anti-VEGF agents for treatment of severe retinopathy of prematurity (ROP) requires close scrutiny and further study.

Prevent Blindness America has designated April as Women’s Eye Health and Safety Month.

The FDA has approved a new drug application for phenylephrine hydrochloride ophthalmic solution, USP 2.5% and 10% (Paragon BioTeck Inc.) to dilate the pupil.

Bausch + Lomb has filed a registration statement with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock.

A new mobile website, DROPS101 Web Tools (Alcon), offers digital access to product information for moxifloxacin related to the treatment of bacterial conjunctivitis in children.

Moscone Center at the heart of annual meeting’s ophthalmic sessions, exhibition hall

Third annual meeting delivers on innovative educational program

Achieve more accurate findings by eliminating the effects of artifacts

Use of laser remains standard primary therapy in most populations

Uncertainty outweighs risks, benefits of simultaneous crosslinking to prevent postLASIK ectasia